nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Superinfection—Fluorouracil—colon cancer	0.0621	0.0621	CcSEcCtD
Cefoxitin—Superinfection—Capecitabine—colon cancer	0.0434	0.0434	CcSEcCtD
Cefoxitin—Azotaemia—Vincristine—colon cancer	0.0284	0.0284	CcSEcCtD
Cefoxitin—Local reaction—Fluorouracil—colon cancer	0.0255	0.0255	CcSEcCtD
Cefoxitin—Prothrombin level increased—Capecitabine—colon cancer	0.024	0.024	CcSEcCtD
Cefoxitin—Bone marrow depression—Vincristine—colon cancer	0.0224	0.0224	CcSEcCtD
Cefoxitin—Tenderness—Fluorouracil—colon cancer	0.0162	0.0162	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Irinotecan—colon cancer	0.0156	0.0156	CcSEcCtD
Cefoxitin—Bone marrow depression—Capecitabine—colon cancer	0.0146	0.0146	CcSEcCtD
Cefoxitin—Colitis—Irinotecan—colon cancer	0.0141	0.0141	CcSEcCtD
Cefoxitin—Azotaemia—Methotrexate—colon cancer	0.0138	0.0138	CcSEcCtD
Cefoxitin—Rash maculo-papular—Fluorouracil—colon cancer	0.0128	0.0128	CcSEcCtD
Cefoxitin—Thrombophlebitis—Irinotecan—colon cancer	0.0124	0.0124	CcSEcCtD
Cefoxitin—Thrombophlebitis—Fluorouracil—colon cancer	0.0118	0.0118	CcSEcCtD
Cefoxitin—Renal failure acute—Irinotecan—colon cancer	0.0116	0.0116	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Irinotecan—colon cancer	0.0113	0.0113	CcSEcCtD
Cefoxitin—Bone marrow depression—Methotrexate—colon cancer	0.0109	0.0109	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Capecitabine—colon cancer	0.0104	0.0104	CcSEcCtD
Cefoxitin—Colitis—Capecitabine—colon cancer	0.00947	0.00947	CcSEcCtD
Cefoxitin—Candida infection—Capecitabine—colon cancer	0.00941	0.00941	CcSEcCtD
Cefoxitin—Pancytopenia—Vincristine—colon cancer	0.00901	0.00901	CcSEcCtD
Cefoxitin—Neutropenia—Vincristine—colon cancer	0.00887	0.00887	CcSEcCtD
Cefoxitin—Eosinophilia—Fluorouracil—colon cancer	0.00876	0.00876	CcSEcCtD
Cefoxitin—Neutropenia—Irinotecan—colon cancer	0.00864	0.00864	CcSEcCtD
Cefoxitin—Pancytopenia—Fluorouracil—colon cancer	0.00841	0.00841	CcSEcCtD
Cefoxitin—Phlebitis—Capecitabine—colon cancer	0.00831	0.00831	CcSEcCtD
Cefoxitin—Thrombophlebitis—Capecitabine—colon cancer	0.00827	0.00827	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Capecitabine—colon cancer	0.00819	0.00819	CcSEcCtD
Cefoxitin—Jaundice—Irinotecan—colon cancer	0.00803	0.00803	CcSEcCtD
Cefoxitin—Haemolytic anaemia—Capecitabine—colon cancer	0.00793	0.00793	CcSEcCtD
Cefoxitin—Renal failure acute—Capecitabine—colon cancer	0.00775	0.00775	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Capecitabine—colon cancer	0.00758	0.00758	CcSEcCtD
Cefoxitin—Urinary tract disorder—Vincristine—colon cancer	0.0075	0.0075	CcSEcCtD
Cefoxitin—Urethral disorder—Vincristine—colon cancer	0.00745	0.00745	CcSEcCtD
Cefoxitin—Haemoglobin—Irinotecan—colon cancer	0.00743	0.00743	CcSEcCtD
Cefoxitin—Haemorrhage—Irinotecan—colon cancer	0.0074	0.0074	CcSEcCtD
Cefoxitin—Agranulocytosis—Fluorouracil—colon cancer	0.00737	0.00737	CcSEcCtD
Cefoxitin—Vaginal inflammation—Methotrexate—colon cancer	0.00734	0.00734	CcSEcCtD
Cefoxitin—Haemoglobin—Fluorouracil—colon cancer	0.00712	0.00712	CcSEcCtD
Cefoxitin—Haemorrhage—Fluorouracil—colon cancer	0.00708	0.00708	CcSEcCtD
Cefoxitin—Vaginal infection—Methotrexate—colon cancer	0.00693	0.00693	CcSEcCtD
Cefoxitin—Aplastic anaemia—Methotrexate—colon cancer	0.00689	0.00689	CcSEcCtD
Cefoxitin—Flushing—Irinotecan—colon cancer	0.00687	0.00687	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00644	0.00644	CcSEcCtD
Cefoxitin—Erythema—Fluorouracil—colon cancer	0.00617	0.00617	CcSEcCtD
Cefoxitin—Thrombophlebitis—Methotrexate—colon cancer	0.00615	0.00615	CcSEcCtD
Cefoxitin—Anaemia—Vincristine—colon cancer	0.00611	0.00611	CcSEcCtD
Cefoxitin—Anaemia—Irinotecan—colon cancer	0.00595	0.00595	CcSEcCtD
Cefoxitin—Leukopenia—Vincristine—colon cancer	0.00592	0.00592	CcSEcCtD
Cefoxitin—Pancytopenia—Capecitabine—colon cancer	0.00587	0.00587	CcSEcCtD
Cefoxitin—Neutropenia—Capecitabine—colon cancer	0.00578	0.00578	CcSEcCtD
Cefoxitin—Renal failure acute—Methotrexate—colon cancer	0.00577	0.00577	CcSEcCtD
Cefoxitin—Leukopenia—Irinotecan—colon cancer	0.00576	0.00576	CcSEcCtD
Cefoxitin—Convulsion—Vincristine—colon cancer	0.00573	0.00573	CcSEcCtD
Cefoxitin—Anaemia—Fluorouracil—colon cancer	0.0057	0.0057	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Methotrexate—colon cancer	0.00565	0.00565	CcSEcCtD
Cefoxitin—Leukopenia—Fluorouracil—colon cancer	0.00552	0.00552	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00547	0.00547	CcSEcCtD
Cefoxitin—Anaphylactic shock—Vincristine—colon cancer	0.0054	0.0054	CcSEcCtD
Cefoxitin—Jaundice—Capecitabine—colon cancer	0.00538	0.00538	CcSEcCtD
Cefoxitin—Convulsion—Fluorouracil—colon cancer	0.00534	0.00534	CcSEcCtD
Cefoxitin—Thrombocytopenia—Vincristine—colon cancer	0.00528	0.00528	CcSEcCtD
Cefoxitin—Anaphylactic shock—Irinotecan—colon cancer	0.00526	0.00526	CcSEcCtD
Cefoxitin—Agranulocytosis—Capecitabine—colon cancer	0.00515	0.00515	CcSEcCtD
Cefoxitin—Thrombocytopenia—Irinotecan—colon cancer	0.00515	0.00515	CcSEcCtD
Cefoxitin—Hypotension—Vincristine—colon cancer	0.00504	0.00504	CcSEcCtD
Cefoxitin—Anaphylactic shock—Fluorouracil—colon cancer	0.00503	0.00503	CcSEcCtD
Cefoxitin—Haemoglobin—Capecitabine—colon cancer	0.00498	0.00498	CcSEcCtD
Cefoxitin—Haemorrhage—Capecitabine—colon cancer	0.00495	0.00495	CcSEcCtD
Cefoxitin—Thrombocytopenia—Fluorouracil—colon cancer	0.00493	0.00493	CcSEcCtD
Cefoxitin—Hypotension—Irinotecan—colon cancer	0.00491	0.00491	CcSEcCtD
Cefoxitin—Urinary tract disorder—Capecitabine—colon cancer	0.00489	0.00489	CcSEcCtD
Cefoxitin—Urethral disorder—Capecitabine—colon cancer	0.00485	0.00485	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.0048	0.0048	CcSEcCtD
Cefoxitin—Hypotension—Fluorouracil—colon cancer	0.0047	0.0047	CcSEcCtD
Cefoxitin—Dyspnoea—Irinotecan—colon cancer	0.00469	0.00469	CcSEcCtD
Cefoxitin—Erythema multiforme—Capecitabine—colon cancer	0.00468	0.00468	CcSEcCtD
Cefoxitin—Pain—Vincristine—colon cancer	0.00461	0.00461	CcSEcCtD
Cefoxitin—Flushing—Capecitabine—colon cancer	0.00459	0.00459	CcSEcCtD
Cefoxitin—Eosinophilia—Methotrexate—colon cancer	0.00456	0.00456	CcSEcCtD
Cefoxitin—Pain—Irinotecan—colon cancer	0.00449	0.00449	CcSEcCtD
Cefoxitin—Dyspnoea—Fluorouracil—colon cancer	0.00449	0.00449	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Vincristine—colon cancer	0.00441	0.00441	CcSEcCtD
Cefoxitin—Pancytopenia—Methotrexate—colon cancer	0.00437	0.00437	CcSEcCtD
Cefoxitin—Erythema—Capecitabine—colon cancer	0.00431	0.00431	CcSEcCtD
Cefoxitin—Neutropenia—Methotrexate—colon cancer	0.00431	0.00431	CcSEcCtD
Cefoxitin—Pain—Fluorouracil—colon cancer	0.0043	0.0043	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Irinotecan—colon cancer	0.0043	0.0043	CcSEcCtD
Cefoxitin—Abdominal pain—Vincristine—colon cancer	0.00427	0.00427	CcSEcCtD
Cefoxitin—Body temperature increased—Vincristine—colon cancer	0.00427	0.00427	CcSEcCtD
Cefoxitin—Abdominal pain—Irinotecan—colon cancer	0.00415	0.00415	CcSEcCtD
Cefoxitin—Body temperature increased—Irinotecan—colon cancer	0.00415	0.00415	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00407	0.00407	CcSEcCtD
Cefoxitin—Urticaria—Fluorouracil—colon cancer	0.004	0.004	CcSEcCtD
Cefoxitin—Anaemia—Capecitabine—colon cancer	0.00398	0.00398	CcSEcCtD
Cefoxitin—Body temperature increased—Fluorouracil—colon cancer	0.00398	0.00398	CcSEcCtD
Cefoxitin—Hypersensitivity—Vincristine—colon cancer	0.00398	0.00398	CcSEcCtD
Cefoxitin—Hypersensitivity—Irinotecan—colon cancer	0.00387	0.00387	CcSEcCtD
Cefoxitin—Leukopenia—Capecitabine—colon cancer	0.00386	0.00386	CcSEcCtD
Cefoxitin—Agranulocytosis—Methotrexate—colon cancer	0.00383	0.00383	CcSEcCtD
Cefoxitin—Hypersensitivity—Fluorouracil—colon cancer	0.00371	0.00371	CcSEcCtD
Cefoxitin—Haemoglobin—Methotrexate—colon cancer	0.0037	0.0037	CcSEcCtD
Cefoxitin—Diarrhoea—Vincristine—colon cancer	0.00369	0.00369	CcSEcCtD
Cefoxitin—Haemorrhage—Methotrexate—colon cancer	0.00369	0.00369	CcSEcCtD
Cefoxitin—Urinary tract disorder—Methotrexate—colon cancer	0.00364	0.00364	CcSEcCtD
Cefoxitin—Urethral disorder—Methotrexate—colon cancer	0.00361	0.00361	CcSEcCtD
Cefoxitin—Diarrhoea—Irinotecan—colon cancer	0.0036	0.0036	CcSEcCtD
Cefoxitin—Pruritus—Fluorouracil—colon cancer	0.00356	0.00356	CcSEcCtD
Cefoxitin—Erythema multiforme—Methotrexate—colon cancer	0.00348	0.00348	CcSEcCtD
Cefoxitin—Diarrhoea—Fluorouracil—colon cancer	0.00344	0.00344	CcSEcCtD
Cefoxitin—Thrombocytopenia—Capecitabine—colon cancer	0.00344	0.00344	CcSEcCtD
Cefoxitin—Vomiting—Vincristine—colon cancer	0.00343	0.00343	CcSEcCtD
Cefoxitin—Rash—Vincristine—colon cancer	0.0034	0.0034	CcSEcCtD
Cefoxitin—Dermatitis—Vincristine—colon cancer	0.0034	0.0034	CcSEcCtD
Cefoxitin—Vomiting—Irinotecan—colon cancer	0.00334	0.00334	CcSEcCtD
Cefoxitin—Rash—Irinotecan—colon cancer	0.00331	0.00331	CcSEcCtD
Cefoxitin—Dermatitis—Irinotecan—colon cancer	0.00331	0.00331	CcSEcCtD
Cefoxitin—Hypotension—Capecitabine—colon cancer	0.00329	0.00329	CcSEcCtD
Cefoxitin—Erythema—Methotrexate—colon cancer	0.00321	0.00321	CcSEcCtD
Cefoxitin—Nausea—Vincristine—colon cancer	0.00321	0.00321	CcSEcCtD
Cefoxitin—Vomiting—Fluorouracil—colon cancer	0.0032	0.0032	CcSEcCtD
Cefoxitin—Rash—Fluorouracil—colon cancer	0.00317	0.00317	CcSEcCtD
Cefoxitin—Dermatitis—Fluorouracil—colon cancer	0.00317	0.00317	CcSEcCtD
Cefoxitin—Dyspnoea—Capecitabine—colon cancer	0.00314	0.00314	CcSEcCtD
Cefoxitin—Nausea—Irinotecan—colon cancer	0.00312	0.00312	CcSEcCtD
Cefoxitin—Pain—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Cefoxitin—Nausea—Fluorouracil—colon cancer	0.00299	0.00299	CcSEcCtD
Cefoxitin—Anaemia—Methotrexate—colon cancer	0.00297	0.00297	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Capecitabine—colon cancer	0.00288	0.00288	CcSEcCtD
Cefoxitin—Leukopenia—Methotrexate—colon cancer	0.00287	0.00287	CcSEcCtD
Cefoxitin—Urticaria—Capecitabine—colon cancer	0.00279	0.00279	CcSEcCtD
Cefoxitin—Body temperature increased—Capecitabine—colon cancer	0.00278	0.00278	CcSEcCtD
Cefoxitin—Abdominal pain—Capecitabine—colon cancer	0.00278	0.00278	CcSEcCtD
Cefoxitin—Convulsion—Methotrexate—colon cancer	0.00278	0.00278	CcSEcCtD
Cefoxitin—Anaphylactic shock—Methotrexate—colon cancer	0.00262	0.00262	CcSEcCtD
Cefoxitin—Hypersensitivity—Capecitabine—colon cancer	0.00259	0.00259	CcSEcCtD
Cefoxitin—Thrombocytopenia—Methotrexate—colon cancer	0.00256	0.00256	CcSEcCtD
Cefoxitin—Pruritus—Capecitabine—colon cancer	0.00249	0.00249	CcSEcCtD
Cefoxitin—Hypotension—Methotrexate—colon cancer	0.00245	0.00245	CcSEcCtD
Cefoxitin—Diarrhoea—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Cefoxitin—Dyspnoea—Methotrexate—colon cancer	0.00233	0.00233	CcSEcCtD
Cefoxitin—Pain—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Cefoxitin—Vomiting—Capecitabine—colon cancer	0.00224	0.00224	CcSEcCtD
Cefoxitin—Rash—Capecitabine—colon cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Dermatitis—Capecitabine—colon cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Cefoxitin—Nausea—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Cefoxitin—Urticaria—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Abdominal pain—Methotrexate—colon cancer	0.00207	0.00207	CcSEcCtD
Cefoxitin—Body temperature increased—Methotrexate—colon cancer	0.00207	0.00207	CcSEcCtD
Cefoxitin—Hypersensitivity—Methotrexate—colon cancer	0.00193	0.00193	CcSEcCtD
Cefoxitin—Pruritus—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
Cefoxitin—Diarrhoea—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Cefoxitin—Vomiting—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Rash—Methotrexate—colon cancer	0.00165	0.00165	CcSEcCtD
Cefoxitin—Dermatitis—Methotrexate—colon cancer	0.00165	0.00165	CcSEcCtD
Cefoxitin—Nausea—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
